Novel Spiroisatin Derivatives Potentially Useful for Preventing Myocardial Reperfusion Injury

Abstract Ischemia−reperfusion injury remains a major clinical challenge due to mitochondrial dysfunction and cell death. Here we report a novel series of spiroisatin derivatives as modulators of the mitochondrial permeability transition pore (mPTP) targeted at the c-ring of F1/FO-ATP synthase. Structure−activity relationship analysis identified compound 15j with nanomolar in vitro potency in inhibiting mPTP opening while preserving ATP production. Molecular modeling supported distinct binding interactions within the c subunit of F1/FO-ATP synthase, rationalizing observed pharmacodynamics. Beyond mPTP inhibition, 15j positively modulates mitochondrial quality control pathways, including mitophagy and biogenesis, contributing to sustained mitochondrial homeostasis after reperfusion. These findings establish spiroisatin derivatives as a promising class of cardioprotective agents acting through convergent mechanisms on mitochondrial integrity and quality control.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2026-11-17
DOI
https://doi.org/10.1021/acs.jmedchem.6c02055
Primary Topic
Cardiac Ischemia and Reperfusion
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Novel Spiroisatin Derivatives Potentially Useful for Preventing Myocardial Reperfusion Injury

Salvatore Pacifico, Elena Tremoli, Gaia Pedriali, Giampaolo Morciano et al.
2 links
Journal of Medicinal Chemistry
Cardiac Ischemia and Reperfusion
article

Novel Spiroisatin Derivatives Potentially Useful for Preventing Myocardial Reperfusion Injury

Salvatore Pacifico, Elena Tremoli, Gaia Pedriali, Giampaolo Morciano, Delia Preti, Valentina Albanese, Lorenzo Tagliazucchi, Remo Guerrini, Sandro Cosconati, Paolo Pinton, Tiziano De Ventura, Carlotta Giorgi, Michele Roggia, Elena Nicoletta Colarusso, Sara Leo, Ali Mohammad Shaukat, Martina Fabbri
article en

Abstract

Abstract Ischemia−reperfusion injury remains a major clinical challenge due to mitochondrial dysfunction and cell death. Here we report a novel series of spiroisatin derivatives as modulators of the mitochondrial permeability transition pore (mPTP) targeted at the c-ring of F1/FO-ATP synthase. Structure−activity relationship analysis identified compound 15j with nanomolar in vitro potency in inhibiting mPTP opening while preserving ATP production. Molecular modeling supported distinct binding interactions within the c subunit of F1/FO-ATP synthase, rationalizing observed pharmacodynamics. Beyond mPTP inhibition, 15j positively modulates mitochondrial quality control pathways, including mitophagy and biogenesis, contributing to sustained mitochondrial homeostasis after reperfusion. These findings establish spiroisatin derivatives as a promising class of cardioprotective agents acting through convergent mechanisms on mitochondrial integrity and quality control.

Journal of Medicinal Chemistry
University of Parma (IT), University of Campania "Luigi Vanvitelli" (IT), University of Ferrara (IT), University of Bari Aldo Moro (IT)
Ministero della Salute, Universita degli Studi di Bari Aldo Moro, Università degli Studi di Ferrara, Ministero dell'Università e della Ricerca, NextGenerationEU
Good health and well-being
Cardiac Ischemia and Reperfusion
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon